FDA Inspection 1205602 — National Therapy Products Inc.
The FDA completed an inspection of National Therapy Products Inc. on April 20, 2023 in Brampton. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 20, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Brampton (Canada)